ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $17,210,000 | +174.3% | 100,000 | +100.0% | 0.21% | +195.8% |
| Q2 2021 | $6,275,000 | -8.2% | 50,000 | -0.8% | 0.07% | -18.2% |
| Q1 2021 | $6,838,000 | +144.3% | 50,423 | -32.8% | 0.09% | +319.0% |
| Q3 2017 | $2,799,000 | +76.8% | 75,000 | +25.0% | 0.02% | +40.0% |
| Q1 2016 | $1,583,000 | +1.7% | 60,000 | -14.3% | 0.02% | -76.6% |
| Q3 2013 | $1,556,000 | – | 70,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 1,480,060 | $53,563,000 | 85.86% |
| NEXTHERA CAPITAL LP | 217,817 | $7,883,000 | 4.84% |
| Novo Holdings A/S | 903,833 | $32,710,000 | 2.90% |
| SECTORAL ASSET MANAGEMENT INC | 481,765 | $17,435,000 | 1.71% |
| Perceptive Advisors | 589,890 | $21,348,000 | 1.38% |
| RA Capital Management | 318,565 | $11,529,000 | 1.19% |
| OAK RIDGE INVESTMENTS LLC | 1,226,468 | $44,386,000 | 1.15% |
| Granahan Investment Management | 817,149 | $29,573,000 | 0.97% |
| Eventide Asset Management | 428,900 | $15,522,000 | 0.95% |
| QVT Financial LP | 636,764 | $23,044,000 | 0.87% |